International Journal of Pharma Growth Research Review

About the Journal 

The International Journal of Pharma Growth Research Review (IJPGRR) is an international, peer-reviewed, open-access journal that publishes original scholarly work in pharmaceutical sciences, pharmacology, pharmaceutics, pharmaceutical chemistry, pharmaceutical analysis, pharmacognosy, clinical pharmacy, hospital pharmacy, industrial pharmacy, toxicology, biotechnology, and related interdisciplinary pharmaceutical and healthcare disciplines.

The journal provides a platform for researchers, academicians, pharmacists, clinicians, healthcare professionals, pharmaceutical scientists, and industry experts to disseminate original research, systematic reviews, narrative reviews, case-based pharmaceutical studies, experimental investigations, and evidence-based analyses that contribute to pharmaceutical knowledge, drug discovery, healthcare innovation, and pharmaceutical research.

IJPGRR welcomes submissions from diverse geographical regions and encourages research that addresses emerging pharmaceutical challenges, innovative drug development, novel drug delivery systems, translational pharmaceutical research, interdisciplinary healthcare applications, and scientific advancements in pharmaceutical sciences, biotechnology, clinical practice, and public health.

Open Access Policy

The International Journal of Pharma Growth Research Review (IJPGRR) is a fully open-access journal. All published articles are made freely and immediately available online to readers worldwide without subscription charges, registration requirements, or access restrictions.

Readers may read, download, copy, distribute, print, search, link to, and share the full text of published articles, subject to the terms of the applicable Creative Commons license.

The journal supports the principles of open access as outlined by the Budapest Open Access Initiative (BOAI), which advocates for the free availability of scholarly research on the public internet. In accordance with these principles, IJPGRR ensures that published research is accessible to researchers, academicians, clinicians, pharmacists, students, institutions, policymakers, and the scientific community without financial barriers.

There is no embargo period. All articles are available in full text immediately upon publication.

Open Access License

All articles published in the International Journal of Pharma Growth Research Review (IJPGRR) are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Under this license, users are permitted to:

• Share: Copy and redistribute the material in any medium or format.
• Adapt: Remix, transform, and build upon the material for non-commercial purposes.
• Attribute: Give appropriate credit to the original author(s) and the International Journal of Pharma Growth Research Review, provide a link to the license, and indicate if changes were made.
• ShareAlike: Distribute any adapted material under the same CC BY-NC-SA 4.0 license.

Commercial use of published articles is not permitted without prior written permission from the copyright holder(s).

Copyright

Authors retain the copyright of their published articles.

By submitting and publishing an article in International Journal of Pharma Growth Research Review (IJPGRR), authors grant the journal a non-exclusive right to publish, reproduce, distribute, archive, preserve, and make the article publicly available in all formats and media.

Authors may share, distribute, deposit, and reuse their published articles, provided that appropriate acknowledgment is given to the original publication in the International Journal of Pharma Growth Research Review (IJPGRR).

Aims and Scope

IJPGRR is an international, open-access, peer-reviewed academic journal dedicated to publishing high-quality research in pharmaceutical sciences. It provides a platform for researchers, academicians, pharmacists, healthcare professionals, scientists, and industry experts to share original research, review articles, case studies, and scientific innovations that contribute to pharmaceutical sciences, drug discovery, healthcare advancement, and interdisciplinary pharmaceutical research, with a special focus on emerging research and innovative applications.

1. Pharmaceutical Research & Development: Drug discovery, formulation development, and novel drug delivery systems.
2. Pharmacology & Therapeutics: Clinical pharmacology, pharmacokinetics, pharmacodynamics, and therapeutic innovations.
3. Biotechnology & Biopharmaceuticals: Biologics, biosimilars, vaccines, and advanced biotechnological applications.
4. Pharmaceutical Chemistry & Analytical Sciences: Medicinal chemistry, drug analysis, quality control, and stability studies.
5. Clinical & Translational Research: Clinical trials, regulatory compliance, translational medicine, and personalized therapeutics.
6. Pharma Industry & Policy: Drug policy, regulatory affairs, pharmaceutical marketing, and healthcare economics.
7. Herbal & Natural Products: Phytopharmaceuticals, nutraceuticals, herbal formulations, and complementary medicine research.
8. Interdisciplinary Areas: Drug safety, pharmacovigilance, AI in drug development, and innovative pharma technologies.

Review Process and Publication Ethics 

IJPGRR follows the principles and guidance of the Committee on Publication Ethics (COPE) in addressing publication ethics, editorial integrity, complaints, appeals, corrections, retractions, and suspected research misconduct.

1. Peer Review: Each manuscript that passes initial editorial screening is evaluated through a double-anonymous peer-review process by at least two independent reviewers with relevant subject expertise. The final editorial decision is made by the Editor-in-Chief or an assigned handling editor.
2. Plagiarism and Similarity Screening: All submitted manuscripts are screened using Turnitin or an equivalent similarity-checking tool. Similarity reports are assessed by the editorial team in context. Manuscripts found to contain plagiarism, duplicate publication, fabricated data, falsified information, manipulated citations, or other forms of research misconduct may be rejected or withdrawn in accordance with the journal's Publication Ethics and Malpractice Statement.
3. Transparency & Responsibility: Mandatory disclosure of conflicts of interest; clear editorial policies and Article Processing Charges (APCs).

For full details, please refer to the Publication Ethics and Malpractice Statement page

Author & Editor Responsibilities

1. Clear authorship criteria and contributor transparency
2. Mandatory disclosure of conflicts of interest
3. Ethical handling of research data, references, and citations
4. Editorial independence, accountability, and fairness

Indexing & Visibility

IJPGRR is committed to maximizing the visibility and academic impact of published research. The journal is currently indexed and tracked in:

1. Google Scholar: Published articles may be discoverable through Google Scholar, subject to Google Scholar's indexing process and technical requirements.
2. Crossref DOI Registration: Digital Object Identifiers (DOIs) are registered through Crossref for articles to which a DOI is assigned, in accordance with the journal's DOI policy.
3. ROAD (Directory of Open Access Scholarly Resources): The journal is listed in ROAD, a directory managed by the ISSN International Centre for open-access scholarly resources.

The journal will update this page whenever it is accepted for inclusion in additional indexing and abstracting services.

Article Processing Charges (APC)

The International Journal of Pharma Growth Research Review (IJPGRR) is a fully open-access journal. There is no submission fee and no peer-review fee.

An Article Processing Charge (APC) is payable only after a manuscript has successfully completed peer review and has been formally accepted for publication.

Publication Fee: USD 35 / INR 2,000 per accepted article.

The standard APC covers up to five authors. Additional charges may apply for manuscripts with more than five authors, as detailed in the Author Fees (APC) Policy.

The APC supports editorial handling, double-anonymous peer review, similarity screening, typesetting, online publication, digital archiving, and publication-related administrative services.

Authors should review the complete Author Fees (APC) Policy before submitting a manuscript.

Why Choose IJPGARR?

1. Immediate open access to published articles
2. Double-anonymous peer review
3. Author-retained copyright under CC BY-NC-SA 4.0
4. Editorial board information available publicly
5. Transparent publication ethics, peer-review, and APC policies
6. Half-Yearly publication schedule

Submission

Authors may submit their manuscripts via email at [email protected] or through the online submission system using this link: (Submit Manuscript)